CD38-targeted 89Zr-DFO-daratumumab PET of myeloma: Immuno-PET impacting clinical care Editorial
| Authors: | Ulaner, G. A.; Lewis, J.; Landgren, O. |
| Title: | CD38-targeted 89Zr-DFO-daratumumab PET of myeloma: Immuno-PET impacting clinical care |
| Keywords: | adult; clinical article; aged; lenalidomide; clinical trial; case report; note; nuclear magnetic resonance imaging; positron emission tomography; computer assisted tomography; phase 2 clinical trial; dexamethasone; immunoglobulin; immune response; radiography; zirconium 89; myeloma; human; male; article; daratumumab; positron emission tomography-computed tomography |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 66 |
| Issue: | 3 |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2025-03-01 |
| Start Page: | 482 |
| Language: | English |
| DOI: | 10.2967/jnumed.124.269393 |
| PUBMED: | 39884767 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
